For research and education only · Not reviewed by a medical professional · Disclaimer

Peptide encyclopedia/ Thymulin
Illustration for Thymulin

THE PEPSRADAR ENCYCLOPEDIA

Thymulin

Zinc status and thymic signaling

Research topics · Sources checked 2026-10-04

Read the studies ↓

Thymulin · KEY FACTS

Content updated · how dates work

Saved peptides

What is Thymulin?

Thymulin is a thymic peptide whose biological activity depends on zinc. The featured human study examined zinc status and thymulin activity; it was not a trial of thymulin injections.

Biological role or research focus

Zinc status and thymic signaling.

These findings do not establish clinical benefit from injecting thymulin or treating people who are not zinc deficient.

Role reference: Serum thymulin in human zinc deficiency. · 1988 ↗

Names you may encounter

Serum thymic factor · FTS

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Zinc-dependent thymic peptide activity
Research focus
Zinc status and thymic signaling
Featured evidence
Human physiological study
Source check
October 4, 2026

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Quick answers

Is Thymulin FDA approved?
No. No FDA-approved drug contains Thymulin. FDA lists it in 503A category 3: nominated for compounding without enough supporting information. Source ↗
Is Thymulin safe?
Not an approved drug. Studies measure the body's own thymulin; no published human safety studies of giving thymulin were found, so its risks are unknown. Human safety data: none. The Risks & interactions section below lists what is known. Read the risks ↓
Is Thymulin banned in sport?
Very likely. The 2026 World Anti-Doping Agency (WADA) Prohibited List does not name it, but it appears to fall under a banned class (S0 Non-approved substances). Source ↗

What does the evidence show?

Evidence map

Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.

1 Human research
StudyTypePopulation / model
Zinc status and thymulin activity (1988)Human physiological study14 participants across experimentally induced zinc deficiency, sickle-cell anemia, and other clinical groups.

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Human physiological study · 1988

Zinc status and thymulin activity

What did this publication test, and what did it find?

Population / model
14 participants across experimentally induced zinc deficiency, sickle-cell anemia, and other clinical groups.
Study design
Small physiological comparisons with zinc-related interventions and laboratory restoration experiments.
Main finding
Thymulin activity was lower in zinc-deficient settings and was restored with zinc in the reported in-vivo and in-vitro experiments.
Limits & context
These findings do not establish clinical benefit from injecting thymulin or treating people who are not zinc deficient.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Registered human trials

No study naming Thymulin as an intervention was found on ClinicalTrials.gov when we last checked (November 16, 2026). That means no registered human trial, not proof that none has ever been done elsewhere.

Further reading · 4 additional publication links

Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.

Zinc status of Indian children. ↗
The Indian journal of medical research · 1995 Nov · Journal Article, Review

Thymic endocrinology. ↗
Annals of the New York Academy of Sciences · 1998 May 1 · Journal Article, Review

Thymic endocrinology. ↗
International journal of immunopharmacology · 1992 Apr · Journal Article, Review

Zinc: an overview. ↗
Nutrition (Burbank, Los Angeles County, Calif.) · 1995 Jan-Feb · Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review

Repeat this PubMed search ↗
Search additional PubMed records ↗

Risks & interactions

Not an approved drug. Studies measure the body's own thymulin; no published human safety studies of giving thymulin were found, so its risks are unknown.

Human safety data: None

No published studies of giving thymulin to people were found. Human research measured natural thymulin activity in zinc deficiency, which cannot define the risks of an administered product.

Unassessed: no human safety data

It isn't approved, so there is no official list of who should avoid it, and no human safety studies have been published. No condition is tagged, but that does not make it safe for anyone. If a condition applies to you, talk to a doctor or pharmacist first.

Who should not use it

There is no official list, because it has never been approved as a medicine. That is not a sign it is safe for anyone: its risks have not been studied enough to know who is most at risk.

Summarized from published studies with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: Serum thymulin in human zinc deficiency (1988) ↗ · Thymic endocrinology (review, 1998) ↗

Safety & what remains unknown

The paper is not an administered-thymulin safety study and cannot define such a preparation’s clinical risk.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Evidence boundaries

These findings do not establish clinical benefit from injecting thymulin or treating people who are not zinc deficient.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Regulatory status

U.S. FDA approval
Not approved
No FDA-approved drug containing this substance found in Drugs@FDA (openFDA data updated 2026-10-07). source
FDA compounding (503A bulk list)
Category 3 (nominated without enough support)
Listed in 503A category 3 ("Thymulin acetate", nominated without adequate support). source
World Anti-Doping Agency (2026)
Likely prohibited under a class rule · S0 Non-approved substances
Not named. S0 prohibits (at all times) any pharmacological substance not covered by another section and with no current approval by any government health authority for human therapeutic use; no such approval was found, so it is likely covered. source

Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

Research context & identity

This profile concerns immune-endocrine physiology and zinc-associated laboratory measures, rather than an established immune-boosting product.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Sources & supplier listings

Seller lab-report checks and prices are available to members. Sign up free

Biology & proposed mechanism

The study tested whether zinc availability affects measured thymulin activity. Restoring a biomarker with zinc is different from demonstrating an effect of administered thymulin.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Questions worth asking

  • Did the study test thymulin injections?
  • What material, population, and route were actually studied?
  • These findings do not establish clinical benefit from injecting thymulin or treating people who are not zinc deficient.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Video & podcast discussions: members library

Frequently asked questions

Did the study test thymulin injections?

No. It investigated zinc status and thymulin activity, including zinc-related restoration experiments.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

Does the publication verify a supplier’s product?

No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.

Source: Serum thymulin in human zinc deficiency. · 1988 ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

See something wrong on this page? Report a mistake · Corrections